ML17102B375

Shine Medical Technologies, Inc. - Acknowledgment of Change of Mailing Address

ML17102B375
Person / Time
Site:	SHINE Medical Technologies
Issue date:	04/17/2017
From:	Steven Lynch NRC/NRR/DPR/PRLB
To:	Piefer G SHINE Medical Technologies
Lynch S
References
Download: ML17102B375 (1)

Text

April 17, 2017 Gregory Piefer, Ph.D.

Chief Executive Officer SHINE Medical Technologies, Inc.

101 E. Milwaukee Street, Suite 600 Janesville, WI 53545

SUBJECT:

SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF CHANGE OF MAILING ADDRESS

Dear Dr. Piefer:

By letter dated December 9, 2016 (Agencywide Documents Access and Management System

[ADAMS] Accession No. ML16344A021), SHINE Medical Technologies, Inc. (SHINE) informed the U.S. Nuclear Regulatory Commission (NRC) of a change in its mailing address.

The NRC has updated its records to reflect this change and will send all correspondence to the following mailing address:

SHINE Medical Technologies, Inc.

101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.

Sincerely,

/RA/

Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608

ML17102B375; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB/PM* NRR/DPR/PROB/LA* NRR/DPR/PRLB/BC NAME SLynch NParker AAdams DATE 4/13/17 4/13/17 4/17/17